NEW OPPORTUNITIES OF TREATMENT OF DIFFERENT TYPES OF JUVENILE ARTHRITIS WITH MONOCLONAL ANTIBODIES TO THE INTERLEUKIN 6 RECEPTOR

• Main Authors: E.I. Alexeeva (Author), R.V. Denisova (Author), S.I. Valieva (Author), T.M. Bzarova (Author), A.O. Lisitsyn (Author)
• Format: Book
• Published: "Paediatrician" Publishers LLC, 2010-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Summary

<p><em>The article observes the data on the role of interleukin (IL) 6 in pathogenesis of rheumatoid arthritis and treatment of rheumatoid arthritis and different types of juvenile arthritis with blocker IL 6 receptor (tocilizumab). The data on multicenter open-labeled and double-blinded randomized studies on effectiveness and safety of tocilizumab are reviewed. The results of studies showed high effectiveness and safety of tocilizumab in treatment of rheumatoid arthritis and juvenile arthritis. </em><strong><em></em></strong></p><p><strong><em>Key words: children, rheumatoid arthritis, juvenile arthritis, interleukin 6, treatment, tocilizumab.</em></strong><br /><span style="text-decoration: underline;"><em>(<em><em><em>Voprosy sovremennoi pediatrii - </em></em></em>Current Pediatrics. 2010;9(1):52-61)</em></span></p>

Item Description

1682-5527
1682-5535